- BASF is selling its optical brightening agent business to Catexel.
- The transaction includes production in Monthey, Switzerland, and 80 employees.
- Closing is expected in the first quarter of 2026.
- Financial details of the transaction are undisclosed.
Transaction Overview
BASF has agreed to sell its optical brightening agent business to Catexel. This business, part of BASF's Care Chemicals division, includes production at the Monthey site in Switzerland and involves approximately 80 employees. The financial details of the transaction remain undisclosed.
Strategic Alignment
This divestment is part of BASF's strategic transformation, aligning with its 'Winning Ways' strategy to actively manage and prioritize its portfolio. The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions.
Catexel's Expansion
Catexel, part of the International Chemical Investors Group, specializes in specialty chemicals for detergents, personal care, and industrial applications. By acquiring BASF's optical brightening agent business, Catexel aims to expand its portfolio in the detergent industry, enhancing its position as a reliable market partner.
